CTC_3_600_300Many thanks to members for the kind words you have extended to the BIA team for the fantastic job they did at BIO in San Diego last week. I think we are just about back on timezone. It was great to see such a big and busy delegation throughout the week. A number of global reports benchmarking our sector were launched there– and EY’s Beyond Borders is well worth a look. The adaptive licensing agenda was also featured in a super session at BIO, and our report and blog of the event we hosted in June are now available. Expect to see more announcements on successful pilot applications in the coming days.

I hope our press releases on David Willetts support for the sector, the global profile of the UK Early Access scheme and the International Council of Biotech Associations adopting antimicrobial resistance (AMR) as an inaugural priority provided the mood music to the deals being done in the partnering meetings.

Last week saw the official opening of the Cell Therapy Catapult’s new facilities by Secretary of State for Business, Innovation and Skills, Vince Cable MP, pictured above. Read our guest blog by CEO Keith Thompson to find out more about what to expect from the centre in the coming months and how to get in touch if you would like to visit the lab facilities.

It was great to see AMR win the £10 million Longitude Award too – inspiring and educational to see this challenge voted for by the British public.

On the events front this week, One Nucleus host their ON Helix conference with a stellar lineup of speakers on Wednesday in Cambridge, whilst student-led Oxbridge Biotech Roundtable are running their Europe OneStart demo night on Thursday in London from where the next generation of companies may just emerge – see their upcoming events here.

One final reminder that our UK CEO and Investor Forum is just over a week away – if you do want to join us please book this week as accommodation is running short.

Best,

Steve